GLP-1 receptor agonists are injectable or oral medications that enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite
More than 100 million Americans, including nearly 42% of adults ages 60 and older, are living with obesity, a chronic condition that puts them at high risk for a variety of serious conditions, including heart disease, stroke, diabetes and cancer
It contains the active ingredient semaglutide, which is part of a drug class called glucagon-like peptide-1 (GLP-1) receptor agonists
Treatment is provided only after an in-person medical evaluation confirming clinical appropriateness
It "only requires a one-step conversion to the active form of retinoic acid, unlike retinol, which requires a two-step conversion, says Hee Jin Koh, MD, a board-certified dermatologist based in Clifton, New Jersey